Denmark · Delayed Price · Currency is DKK BioPorto Statistics
Total Valuation
BioPorto has a market cap or net worth of DKK 465.40 million. The enterprise value is 418.03 million.
| Market Cap | 465.40M |
| Enterprise Value | 418.03M |
Important Dates
The last earnings date was Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioPorto has 495.11 million shares outstanding. The number of shares has increased by 32.47% in one year.
| Current Share Class | 495.11M |
| Shares Outstanding | 495.11M |
| Shares Change (YoY) | +32.47% |
| Shares Change (QoQ) | +79.79% |
| Owned by Insiders (%) | 2.19% |
| Owned by Institutions (%) | 0.05% |
| Float | 484.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.55 |
| PB Ratio | 7.39 |
| P/TBV Ratio | 7.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.09 |
| EV / Sales | 10.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.12.
| Current Ratio | 3.25 |
| Quick Ratio | 2.81 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -138.26 |
Financial Efficiency
Return on equity (ROE) is -125.60% and return on invested capital (ROIC) is -65.56%.
| Return on Equity (ROE) | -125.60% |
| Return on Assets (ROA) | -51.80% |
| Return on Invested Capital (ROIC) | -65.56% |
| Return on Capital Employed (ROCE) | -116.90% |
| Weighted Average Cost of Capital (WACC) | 10.34% |
| Revenue Per Employee | 875,804 |
| Profits Per Employee | -1.79M |
| Employee Count | 46 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.42 |
Taxes
| Income Tax | -5.52M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.85% in the last 52 weeks. The beta is 1.12, so BioPorto's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -29.85% |
| 50-Day Moving Average | 0.93 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 52.50 |
| Average Volume (20 Days) | 474,634 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioPorto had revenue of DKK 40.29 million and -82.12 million in losses. Loss per share was -0.15.
| Revenue | 40.29M |
| Gross Profit | 30.39M |
| Operating Income | -78.39M |
| Pretax Income | -87.64M |
| Net Income | -82.12M |
| EBITDA | -77.64M |
| EBIT | -78.39M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 54.89 million in cash and 7.52 million in debt, with a net cash position of 47.37 million or 0.10 per share.
| Cash & Cash Equivalents | 54.89M |
| Total Debt | 7.52M |
| Net Cash | 47.37M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 63.01M |
| Book Value Per Share | 0.13 |
| Working Capital | 58.83M |
Cash Flow
| Operating Cash Flow | -77.07M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 754,000 |
| Net Borrowing | -3.80M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.44%, with operating and profit margins of -194.59% and -203.83%.
| Gross Margin | 75.44% |
| Operating Margin | -194.59% |
| Pretax Margin | -217.53% |
| Profit Margin | -203.83% |
| EBITDA Margin | -192.72% |
| EBIT Margin | -194.59% |
| FCF Margin | n/a |
Dividends & Yields
BioPorto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.47% |
| Shareholder Yield | -32.47% |
| Earnings Yield | -17.64% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioPorto has an Altman Z-Score of 4.04 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.04 |
| Piotroski F-Score | 3 |